Lung cancer database study for newly diagnosed patients
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a new lung cancer diagnosis confirmed by a tissue/cell test, or a suspected lung tumor where cancer treatment is planned
- Your first treatment plan includes one of these: surgery, chemotherapy, chemoradiation, radiation, or targeted therapy
- You have at least one measurable or trackable tumor spot on scans
- You can follow study steps and you agree to sign informed consent
- You receive care at the Pneumology (lung) department of Lille University Hospital and are covered by a social security scheme
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information about people who have been treated for lung or chest cancers at Lyon University Hospital. Your data may help researchers better understand these cancers and improve future care.
This study collects medical data and samples from people with newly diagnosed bronchial cancer to learn more about the disease. You may be able to join if you have not yet started treatment for this cancer.
This trial collects blood and tissue samples from people newly diagnosed with lung cancer (NSCLC or CPC) to study the disease over time. It helps researchers understand how different treatments affect the cancer and the body.
This study collects medical information and test results from people with lung cancer that has spread (or cannot be cured with local treatment). It does not test a new drug; it helps researchers better understand patients’ health and care needs over time.
This study collects blood, tissue, and other samples from people with lung nodules, suspected lung cancer, or confirmed lung cancer to find better ways to diagnose and treat the disease. By joining, you help researchers discover new biomarkers that could improve care for future patients.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.